-
Patient Reported Outcomes Webinar 3: Developing New Patient-Reported Outcomes Instruments
Oct 14, 2020, 17:46 PM -
Biosimilars: Unleashing The Potential For Improved Patient Access And Cost Savings In The United States
Oct 12, 2020, 17:24 PM -
ONE HEALTH Perspectives on HEOR
Oct 8, 2020, 18:43 PM -
Methods Maze: Pointers for Selecting Survival Extrapolation Models for Cancer Immunotherapy
Oct 6, 2020, 13:03 PM -
Patient-Reported Outcomes Webinar 1 (3-Part Series): Webinar 1: What are PROs and HRQOL Tools?
Sep 30, 2020, 19:51 PM -
Open Source Models in HEOR: Benefits, Challenges, and ISPOR Members’ Perceptions
Sep 24, 2020, 18:41 PM -
Machine Learning in HEOR
Sep 24, 2020, 17:16 PM -
Pathways to ISPOR Leadership - Jan Hansen
Sep 23, 2020, 13:41 PM -
French Administrative Health Care Database (SNDS): Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
Sep 22, 2020, 18:30 PM -
Balancing Economics and Ethics: How Can VA/HTA Support Equitable Resource Allocation?
Sep 21, 2020, 17:42 PM -
COVID-19: Are Our Methods Up To The Task?
Aug 27, 2020, 15:33 PM -
Global Experiences with the Use of HTA for Health Benefit Packages Development
Aug 26, 2020, 18:00 PM -
Patient Reported Outcomes in Asia Pacific: Opportunity and Challenges
Aug 24, 2020, 13:04 PM -
The Usage of Real-World Evidence (RWE): Monitoring and Managing Health Technologies In Latin America - Where We Are and Where We Are Heading
Aug 10, 2020, 15:47 PM -
Pathways To ISPOR Leadership – Laura Pizzi
Aug 4, 2020, 14:46 PM -
How Should The COVID-19 Pandemic Challenge Conventional Wisdom About HTA/VA?
Jul 29, 2020, 19:39 PM -
Assessing the Impacts of a Pandemic on Pharmaceutical and Medical Device Utilization
Jul 28, 2020, 00:00 AM -
Patient Engagement in Research: An ISPOR Definition
Jul 17, 2020, 15:17 PM -
Pathways To ISPOR Leadership - Diego Rosselli
Jul 14, 2020, 00:00 AM -
Measurement Comparability Between Modes of Administration of PROMs-Webinar
Jul 1, 2020, 00:00 AM